RxDoctor Payments Data

Ashley Patten

Family · Greenville, SCNPI 1831641596

Payments from drug & device makers

$3,491in general payments, 2019–2025

Across 42 payments — averaging $83.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Boston Scientific$901
  • Endo USA, Inc.$73
  • Johnson & Johnson$69
  • Sumitomo Pharma America, Inc.$51
  • Antares Pharma, Inc.$50
  • plus $231 from 8 others

What the payments were for

  • Travel & lodging$1,91755%
  • Food & beverage$1,57445%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,491 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$11,870
Medicare patients
174
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron30$23,362
MyrbetriqMirabegron32$19,076
Estradiol41$2,773
Tamsulosin Hcl197$2,301
Oxybutynin Chloride ErOxybutynin Chloride27$440
Testosterone Cypionate17$393
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst28$385
Finasteride35$330
Ciprofloxacin Hcl56$283
Cephalexin15$124
Fluconazole17$109
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim34$103
Alfuzosin Hcl ErAlfuzosin Hcl15$92
Lorazepam11$13

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$51$23,36230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,248 family providers in South Carolina.

Other family in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →